Empyrean Capital Partners’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,000
Closed -$9.89M 202
2021
Q2
$9.89M Hold
40,000
0.23% 108
2021
Q1
$9.7M Buy
+40,000
New +$9.7M 0.28% 97